REVB
REVELATION BIOSCIENCES, INC.
Company overview
- Market capitalization
- $3.36M
- Employees
- 8
- Latest publication
- 2026-09-29
About REVELATION BIOSCIENCES, INC.
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 1,376,861USD | 964,189USD | 922,857,000,000USD | 1,317,980,000,000USD | 858,830,000,000USD | 605,504,000,000USD | 830,981,000,000USD | 1,394,929,000,000USD |
| Total Operating Expenses | 3,092,500USD | 2,571,587USD | 1,943,011,000,000USD | 2,461,229,000,000USD | 2,094,987,000,000USD | 1,753,888,000,000USD | 1,796,686,000,000USD | 2,522,397,000,000USD |
| Net Income | -3,009,051USD | -2,511,007USD | -1,907,176,000,000USD | -2,444,382,000,000USD | -2,051,085,000,000USD | -1,725,719,000,000USD | -2,600,000USD | -1,400,000USD |
| Source | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | — | 95,812,000USD | 85,113,000USD |
| Cost Of Revenue | 27,058USD | 27,923USD | 25,049USD | 40,008USD | 69,166USD | — | — | 0USD |
| Gross Profit | -27,058USD | -27,923USD | -25,049USD | -40,008USD | -69,166USD | — | 90,905,000USD | 80,983,000USD |
| Research Development | 4,063,857USD | 3,548,996USD | 4,145,902USD | 5,377,400USD | 6,914,756USD | 2,561USD | — | — |
| Selling General Administrative | 5,006,957USD | 4,426,113USD | 4,510,762USD | 5,487,111USD | 5,035,729USD | 145,492USD | 36,336,000USD | 33,982,000USD |
| Total Operating Expenses | 9,070,814USD | 7,975,109USD | 8,656,664USD | 10,864,511USD | 11,950,485USD | 145,492USD | 3,638USD | 42,089,000USD |
| Operating Income | -9,070,814USD | -7,975,109USD | -8,656,664USD | -10,864,511USD | -11,950,485USD | -145,492USD | -3,638USD | 38,894,000USD |
| Income Before Tax | -8,913,649USD | -15,038,536USD | -120,254USD | -10,829,549USD | -11,986,837USD | -136,408USD | -3,638USD | 37,052,000USD |
| Net Income | -8,913,649USD | -15,038,536USD | -120,254USD | -10,829,549USD | -11,986,837USD | -136,408USD | -3,638USD | 27,627,000USD |
| Net Income From Continuing Ops | -8,913,649USD | -15,038,536USD | 875,063USD | -10,829,549USD | -11,986,837USD | — | 31,698,000USD | 27,627,000USD |
| Ebit | -9,070,814USD | -7,975,109USD | -8,656,664USD | -10,864,511USD | -11,950,485USD | -145,492USD | -175,500USD | 0USD |
| Ebitda | -9,043,756USD | -7,947,186USD | -8,631,615USD | -10,839,463USD | -11,933,703USD | -145,492USD | -3,638USD | — |
| Depreciation And Amortization | 27,058USD | 27,923USD | 25,049USD | 25,048USD | 16,782USD | 3,796USD | 171,860USD | — |
| Reconciled Depreciation | 27,058USD | 27,923USD | 25,049USD | 25,048USD | 16,782USD | — | — | — |
| Total Other Income Expense Net | 157,165USD | -7,063,427USD | 8,536,410USD | 34,962USD | -36,352USD | 9,084USD | 2USD | -1,842,000USD |
| Selling And Marketing Expenses | — | — | 25,049USD | — | — | 144,257USD | — | — |
| Income Tax Expense | — | — | 1USD | -34,962USD | -219,776USD | -3,796USD | -171,860USD | 9,425,000USD |
| Interest Expense | — | — | — | 34,962USD | 41,759USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | -2,130,625USD | -3,795,693USD | 31,698,000USD | 27,627,000USD |
| Other Operating Expenses | — | — | — | — | — | 145,492USD | — | 4,070,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | -36,332,362USD | 4,037,000USD |
| Interest Income | — | — | — | — | — | — | 129,341,000USD | 106,973,000USD |
| Net Interest Income | — | — | — | — | — | — | 92,868,000USD | 82,842,000USD |
| Tax Provision | — | — | — | — | — | — | 11,600,000USD | 9,425,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 12,497,932USD | 15,044,282USD | 11,582,924USD | 12,856,342USD | 5,395,090USD | 3,970,271USD | 6,622,049USD | 6,740,140USD |
| Cash And Equivalents | 11,482,792USD | 14,113,415USD | 10,700,331USD | 12,708,489USD | 5,173,871USD | 3,704,611USD | 6,499,018USD | 6,541,052USD |
| Total Current Assets | 11,684,516USD | 14,206,035USD | 10,811,628USD | 12,832,423USD | 5,359,920USD | 3,927,881USD | 6,565,717USD | 6,658,898USD |
| Other Current Assets | 201,724USD | 92,620USD | 111,297USD | 123,934USD | 186,049USD | 223,270USD | 66,699USD | 117,846USD |
| Other Non Current Assets | 30,941USD | 30,941USD | 30,941USD | — | — | — | — | — |
| Total Liabilities | 2,430,946USD | 2,055,329USD | 2,721,929USD | 1,854,507USD | 1,569,306USD | 1,089,519USD | 1,913,667USD | 4,066,523USD |
| Total Current Liabilities | 1,880,400USD | 1,417,146USD | 1,998,158USD | 1,854,507USD | 1,569,306USD | 1,089,519USD | 1,913,667USD | 4,066,523USD |
| Other Current Liabilities | 759,937USD | 468,082USD | 1,397,644USD | 819,381USD | 739,626USD | 463,632USD | 1,127,800USD | 934,372USD |
| Total Stockholder Equity | 10,066,986USD | 12,988,953USD | 8,860,995USD | 11,001,835USD | 3,825,784USD | 2,880,752USD | 4,708,382USD | 2,673,617USD |
| Total Equity Including Noncontrolling Interest | 10,066,986USD | 12,988,953USD | 8,860,995USD | 11,001,835USD | 3,825,784USD | 2,880,752USD | 4,708,382USD | 2,673,617USD |
| Property Plant Equipment Net | 782,475USD | 807,306USD | 740,355USD | 23,919USD | 35,170USD | 42,390USD | 56,332USD | 81,242USD |
| Accounts Payable | 931,093USD | 828,203USD | 577,501USD | 1,034,951USD | 828,894USD | 625,058USD | 783,621USD | 3,127,348USD |
| Short Term Debt | 189,370USD | 120,861USD | 23,013USD | — | — | — | — | — |
| Common Stock | 3,908USD | 3,908USD | 1,584USD | 3,586USD | 1,535USD | 964USD | 522USD | 4,292USD |
| Retained Earnings | -55,751,722USD | -52,428,338USD | -49,419,287USD | -46,908,281USD | -45,001,105USD | -42,556,723USD | -40,505,638USD | -38,779,919USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,582,924USD | 6,622,049USD | 12,212,609USD | 5,503,415USD | 48,385,887USD | 74,162,206USD | 2,455,211,000USD | 2,098,845,000USD |
| Cash And Equivalents | 10,700,331USD | 6,499,018USD | 11,991,701USD | 5,252,979USD | 78,532USD | 11,734USD | — | — |
| Total Current Assets | 10,811,628USD | 6,565,717USD | 12,147,525USD | 5,413,282USD | 83,366USD | 651,291USD | 143,296,000USD | 78,080,000USD |
| Other Current Assets | 111,297USD | 66,699USD | 84,691USD | 73,132USD | — | — | 6,854,000USD | 5,868,000USD |
| Other Non Current Assets | 30,941USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,721,929USD | 1,913,667USD | 5,564,894USD | 4,450,962USD | 8,397,377USD | 6,344,910USD | — | — |
| Total Current Liabilities | 1,998,158USD | 1,913,667USD | 5,564,894USD | 4,450,962USD | 5,486,117USD | 3,433,650USD | 2,120,760,000USD | 1,796,021,000USD |
| Other Current Liabilities | 1,397,644USD | 1,127,800USD | 1,152,460USD | 985,497USD | — | 33,772USD | — | — |
| Total Stockholder Equity | 8,860,995USD | 4,708,382USD | 6,647,715USD | 1,052,453USD | -7,822,654USD | -5,692,029USD | 264,891,000USD | 188,277,000USD |
| Total Equity Including Noncontrolling Interest | 8,860,995USD | 4,708,382USD | 6,647,715USD | 1,052,453USD | 39,988,510USD | 67,817,296USD | — | — |
| Property Plant Equipment Net | 740,355USD | 56,332USD | 65,084USD | 90,133USD | — | — | 4,283,000USD | 4,227,000USD |
| Accounts Payable | 577,501USD | 783,621USD | 1,359,898USD | 554,205USD | 784,800USD | — | 1,320,000USD | 929,000USD |
| Short Term Debt | 23,013USD | — | — | — | — | — | 30,473,000USD | — |
| Common Stock | 1,584USD | 522USD | 265USD | 683USD | 1,820USD | 1,820USD | 59,087,000USD | 49,272,000USD |
| Retained Earnings | -49,419,287USD | -40,505,638USD | -25,467,102USD | -25,346,848USD | -7,824,474USD | -5,693,849USD | 62,878,000USD | 35,060,000USD |
| Deferred Revenue Non Current | — | — | — | — | 2,911,260USD | 2,911,260USD | — | — |
| Cash And Short Term Investments | — | — | — | — | — | 537,021USD | — | — |
| Short Term Investments | — | — | — | — | — | 525,287USD | 187,558,000USD | 163,226,000USD |
| Intangible Assets | — | — | — | — | — | — | 3,627,000USD | 4,337,000USD |
| Total Liab | — | — | — | — | — | — | 2,190,320,000USD | 1,910,568,000USD |
| Other Liab | — | — | — | — | — | — | 5,862,000USD | 6,113,000USD |
| Good Will | — | — | — | — | — | — | 26,815,000USD | 26,815,000USD |
| Other Assets | — | — | — | — | — | — | 2,084,934,000USD | 1,817,010,000USD |
| Cash | — | — | — | — | — | — | 136,442,000USD | 72,200,000USD |
| Short Long Term Debt | — | — | — | — | — | — | 30,473,000USD | — |
| Long Term Debt | — | — | — | — | — | — | 94,171,000USD | 108,434,000USD |
| Long Term Investments | — | — | — | — | — | — | 192,256,000USD | 168,376,000USD |
| Net Receivables | — | — | — | — | — | — | 6,854,000USD | 5,868,000USD |
| Net Tangible Assets | — | — | — | — | — | — | 234,449,000USD | 157,125,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | -194,412,000USD | -169,082,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | 2,058,494,000USD | 1,795,092,000USD |
| Unclassified Equity | — | — | — | — | — | — | 142,926,000USD | 103,945,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 7,203USD | 5,852USD | 6,765USD | 7,220USD | 7,221USD | 7,221USD | 7,220USD | 7,220USD |
| Stock Based Compensation | 470,997USD | 370,166USD | 874USD | 873USD | 223,455USD | 72,566USD | 32,095USD | 32,095USD |
| Change To Liabilities | -712,662USD | — | — | — | -822,731USD | — | — | — |
| Change In Working Capital | 177,603USD | 149,453USD | 306,761USD | 517,051USD | -315,134USD | -2,099,152USD | -7,048,693USD | 5,851,238USD |
| Operating Cash Flow | -3,214,851USD | — | — | — | -2,794,407USD | — | — | — |
| Capital Expenditures | -71,879USD | 0USD | 0USD | 0USD | — | -17,691USD | -17,686USD | -19,172USD |
| Investing Cash Flow | -71,879USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 6,699,814USD | — | — | — | — | — | — | — |
| Change In Cash | 3,413,084USD | -2,008,158USD | 7,534,618USD | 1,469,260USD | -2,794,407USD | -42,034USD | -5,532,006USD | -2,478,682USD |
| End Cash Flow | 14,113,415USD | — | — | — | 3,704,611USD | — | — | — |
| Net Income | — | -2,511,006USD | -1,907,176USD | -2,444,382USD | — | -1,725,719USD | -2,241,565USD | -8,389,819USD |
| Other Non Cash Items | — | 18,543USD | 3,875USD | -43USD | — | -2,557USD | -6,041USD | 20,584USD |
| Total Cash From Operating Activities | — | -1,966,992USD | -1,588,901USD | -1,919,281USD | — | -3,747,641USD | -9,256,984USD | -2,478,682USD |
| Free Cash Flow | — | -1,966,990USD | -1,588,901USD | -1,919,281USD | — | -3,729,950USD | -9,274,670USD | -2,478,682USD |
| Total Cash From Financing Activities | — | -41,166USD | 9,123,519USD | 3,388,541USD | — | 3,687,918USD | 3,742,666USD | 5,417,180USD |
| Dividends Paid | — | -5,945,576,472USD | -2,769,742USD | -3,181,786USD | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 3,388,244USD | — | 0USD | 0USD | 0USD |
| Begin Period Cash Flow | — | 12,708,489USD | 5,173,871USD | 3,704,611USD | — | 6,541,052USD | 12,073,058USD | 14,551,740USD |
| End Period Cash Flow | — | 10,700,331USD | 12,708,489USD | 5,173,871USD | — | 6,499,018USD | 6,541,052USD | 12,073,058USD |
| Other Cashflows From Financing Activities | — | 5,945,576,472USD | 2,769,742USD | 3,182,083USD | — | 9,104,971USD | 3,742,666USD | 5,392,180USD |
| Investments | — | — | 0USD | 0USD | — | 17,689USD | -17,688USD | 0USD |
| Total Cashflows From Investing Activities | — | — | 281,967USD | -281,967USD | — | 17,689USD | -17,688USD | — |
| Other Cashflows From Investing Activities | — | — | -281,967USD | 281,967USD | — | -19,132,657USD | -353,544USD | 301,139USD |
| Unclassified Financing Cash Flow | — | — | 9,123,519USD | — | — | -5,417,053USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | 0USD | 0USD | 0USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | 19,150,348USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 27,058USD | 27,923USD | 25,049USD | 25,048USD | — | — | 1,748,000USD | 1,489,000USD |
| Stock Based Compensation | 595,368USD | 168,850USD | 155,721USD | 301,116USD | — | — | — | — |
| Change To Liabilities | 63,636USD | -3,512,197USD | 911,623USD | -1,259,029USD | 2,287,742USD | 33,773USD | 0USD | 0USD |
| Change In Working Capital | -281,659USD | -558,285USD | 738,101USD | -96,998USD | 2,287,742USD | 33,773USD | 3,638USD | -986,000USD |
| Operating Cash Flow | -8,269,581USD | -18,321,276USD | -7,286,286USD | -11,219,396USD | -725,618USD | -215,074USD | — | — |
| Financing Cash Flow | 12,470,894USD | 12,847,764USD | 14,025,008USD | 15,197,646USD | -24,948,161USD | 74,264,723USD | — | — |
| Change In Cash | 4,201,313USD | -5,492,683USD | 6,738,722USD | 3,978,250USD | 66,798USD | — | 10,673,000USD | 65,700,000USD |
| End Cash Flow | 10,700,331USD | 6,499,018USD | 11,991,701USD | 5,252,979USD | 78,532USD | — | — | — |
| Capital Expenditures | — | -19,171USD | — | — | — | — | -526,000USD | -861,000USD |
| Investing Cash Flow | — | -19,171USD | — | — | 25,740,577USD | -74,037,915USD | — | — |
| Net Investments | — | — | — | — | 525,287USD | -527,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | 25,215,290USD | -73,510,915USD | — | — |
| Net Common Stock Issuance | — | — | — | — | -35,500,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | 10,551,839USD | — | 338,179,000USD | 48,435,000USD |
| Net Income | — | — | — | — | — | — | -3,638USD | 27,627,000USD |
| Change To Account Receivables | — | — | — | — | — | — | -814,000USD | -986,000USD |
| Total Cash From Operating Activities | — | — | — | — | — | — | 41,086,000USD | 32,579,000USD |
| Investments | — | — | — | — | — | — | -368,602,000USD | -294,852,000USD |
| Total Cash From Financing Activities | — | — | — | — | — | — | 338,189,000USD | 327,973,000USD |
| End Period Cash Flow | — | — | — | — | — | — | 74,243,480USD | — |
| Other Cashflows From Financing Activities | — | — | — | — | — | — | 10,000USD | 293,888,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | 39,338,000USD | 4,449,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | — | — | -294,852,000USD |
| Net Borrowings | — | — | — | — | — | — | — | -14,350,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 1,470,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 21,206USD | 14,441USD | 20,702USD | 13,482USD | 18,787USD | 12,525USD | 18,786USD | 12,524USD |
| Stock Based Compensation | 225,202USD | 224,328USD | 96,284USD | 64,189USD | 123,626USD | 91,530USD | 268,755USD | 228,080USD |
| Change To Liabilities | -98,255USD | -342,901USD | -1,361,898USD | 5,694,692USD | 770,574USD | -97,949USD | -1,305,183USD | -431,711USD |
| Change In Working Capital | 179,095USD | -74,077USD | 1,734,295USD | -119,627USD | 641,431USD | 200,698USD | -403,698USD | -219,160USD |
| Operating Cash Flow | -6,302,589USD | -4,713,688USD | -14,573,635USD | -5,316,651USD | -5,283,450USD | -3,566,769USD | -10,271,929USD | -8,540,511USD |
| Financing Cash Flow | 12,512,060USD | 3,388,541USD | 9,159,846USD | 5,417,180USD | 14,025,008USD | 14,025,008USD | 15,192,646USD | 10,741,598USD |
| Change In Cash | 6,209,471USD | -1,325,147USD | -5,450,649USD | 81,357USD | 8,741,558USD | 10,458,239USD | 4,920,717USD | 2,201,087USD |
| End Cash Flow | 12,708,489USD | 5,173,871USD | 6,541,052USD | 12,073,058USD | 13,994,537USD | 15,711,218USD | 6,195,446USD | 3,475,816USD |
| Capital Expenditures | — | — | -36,860USD | -19,172USD | — | — | — | — |
| Investing Cash Flow | — | — | -36,860USD | -19,172USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicAmendment | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.